Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (301-310 of 349) with videos related to

Pageof 35
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 2017
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic ModelingSam Salman, Francisca Baiwog, Madhu Page-Sharp, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant womenHarin A Karunajeewa, Sam Salman, Ivo Mueller, et al.
Journal of Clinical Medicine|May 13, 2023
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction ScoresKirsten E Peters, Scott D Bringans, Ronan S O'Neill, et al.
The American Journal of Tropical Medicine and Hygiene|February 4, 2012
Predictors of acute bacterial meningitis in children from a malaria-endemic area of Papua New GuineaMoses Laman, Laurens Manning, Andrew R Greenhill, et al.
The Journal of Infectious Diseases|October 27, 2018
Acquisition of Antibodies Against Endothelial Protein C Receptor-Binding Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Severe MalariaJanavi S Rambhatla, Louise Turner, Laurens Manning, et al.
Diabetes Research and Clinical Practice|March 13, 2024
Not enough known about fenofibrate's kidney effects in people with Type 2 diabetesAlicia J Jenkins, Rachel L O'Connell, Andrzej S Januszewski, et al.
The Journal of Infectious Diseases|February 14, 2014
γδ T cells and CD14+ monocytes are predominant cellular sources of cytokines and chemokines associated with severe malariaDanielle I Stanisic, Julia Cutts, Emily Eriksson, et al.
Cardiovascular Diabetology|November 23, 2011
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialRussell Scott, Mark Donoghoe, Gerald F Watts, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2013
Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malariaBrioni R Moore, Sam Salman, John Benjamin, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 24, 2026
Malaria in Papua New Guinean infants: a prespecified analysis of a randomised postpartum antimalarial treatment trialPaula Tesine, Sze-Ann Woon, Moses Laman, et al.
Pageof 35

Showing results (301-310 of 349) with videos related to

Sort By:
Pageof 35
Antimicrobial Agents and Chemotherapy|March 1, 2017
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic ModelingSam Salman, Francisca Baiwog, Madhu Page-Sharp, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant womenHarin A Karunajeewa, Sam Salman, Ivo Mueller, et al.
Journal of Clinical Medicine|May 13, 2023
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction ScoresKirsten E Peters, Scott D Bringans, Ronan S O'Neill, et al.
The American Journal of Tropical Medicine and Hygiene|February 4, 2012
Predictors of acute bacterial meningitis in children from a malaria-endemic area of Papua New GuineaMoses Laman, Laurens Manning, Andrew R Greenhill, et al.
The Journal of Infectious Diseases|October 27, 2018
Acquisition of Antibodies Against Endothelial Protein C Receptor-Binding Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Severe MalariaJanavi S Rambhatla, Louise Turner, Laurens Manning, et al.
Diabetes Research and Clinical Practice|March 13, 2024
Not enough known about fenofibrate's kidney effects in people with Type 2 diabetesAlicia J Jenkins, Rachel L O'Connell, Andrzej S Januszewski, et al.
The Journal of Infectious Diseases|February 14, 2014
γδ T cells and CD14+ monocytes are predominant cellular sources of cytokines and chemokines associated with severe malariaDanielle I Stanisic, Julia Cutts, Emily Eriksson, et al.
Cardiovascular Diabetology|November 23, 2011
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialRussell Scott, Mark Donoghoe, Gerald F Watts, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2013
Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malariaBrioni R Moore, Sam Salman, John Benjamin, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 24, 2026
Malaria in Papua New Guinean infants: a prespecified analysis of a randomised postpartum antimalarial treatment trialPaula Tesine, Sze-Ann Woon, Moses Laman, et al.
Pageof 35